Free Trial

LivaNova (LIVN) Competitors

LivaNova logo
$48.30 +0.32 (+0.67%)
As of 01/17/2025 04:00 PM Eastern

LIVN vs. PEN, GKOS, STVN, BLCO, INSP, NARI, PRCT, NVST, IRTC, and NVCR

Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Penumbra (PEN), Glaukos (GKOS), Stevanato Group (STVN), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), PROCEPT BioRobotics (PRCT), Envista (NVST), iRhythm Technologies (IRTC), and NovoCure (NVCR). These companies are all part of the "medical equipment" industry.

LivaNova vs.

Penumbra (NYSE:PEN) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability, community ranking, media sentiment and dividends.

Penumbra has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500. Comparatively, LivaNova has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500.

Penumbra has a net margin of 2.97% compared to LivaNova's net margin of 1.91%. LivaNova's return on equity of 13.81% beat Penumbra's return on equity.

Company Net Margins Return on Equity Return on Assets
Penumbra2.97% 8.99% 6.80%
LivaNova 1.91%13.81%7.07%

In the previous week, Penumbra had 1 more articles in the media than LivaNova. MarketBeat recorded 4 mentions for Penumbra and 3 mentions for LivaNova. Penumbra's average media sentiment score of 0.50 beat LivaNova's score of 0.20 indicating that Penumbra is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Penumbra
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LivaNova
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Penumbra has higher revenue and earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Penumbra$1.16B8.71$90.95M$0.86307.07
LivaNova$1.15B2.27$17.55M$0.42115.00

Penumbra received 424 more outperform votes than LivaNova when rated by MarketBeat users. Likewise, 80.29% of users gave Penumbra an outperform vote while only 69.42% of users gave LivaNova an outperform vote.

CompanyUnderperformOutperform
PenumbraOutperform Votes
819
80.29%
Underperform Votes
201
19.71%
LivaNovaOutperform Votes
395
69.42%
Underperform Votes
174
30.58%

88.9% of Penumbra shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 5.0% of Penumbra shares are held by company insiders. Comparatively, 0.3% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Penumbra presently has a consensus price target of $258.00, suggesting a potential downside of 2.30%. LivaNova has a consensus price target of $69.17, suggesting a potential upside of 43.20%. Given LivaNova's stronger consensus rating and higher possible upside, analysts clearly believe LivaNova is more favorable than Penumbra.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Penumbra
0 Sell rating(s)
4 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.80
LivaNova
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
3.00

Summary

Penumbra beats LivaNova on 12 of the 18 factors compared between the two stocks.

Get LivaNova News Delivered to You Automatically

Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIVN vs. The Competition

MetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$2.62B$3.52B$5.21B$9.14B
Dividend YieldN/A1.73%5.13%4.02%
P/E Ratio115.0018.0889.3417.36
Price / Sales2.2769.461,240.0477.11
Price / Cash10.8441.1043.7535.97
Price / Book2.043.915.314.79
Net Income$17.55M$94.49M$122.54M$225.00M
7 Day Performance2.18%4.58%0.59%2.62%
1 Month Performance1.49%4.10%2.55%3.81%
1 Year Performance-3.88%4.21%25.29%20.10%

LivaNova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LIVN
LivaNova
3.3774 of 5 stars
$48.30
+0.7%
$69.17
+43.2%
-3.9%$2.62B$1.15B115.002,900
PEN
Penumbra
3.896 of 5 stars
$244.59
-2.4%
$258.00
+5.5%
+5.5%$9.39B$1.16B284.414,200
GKOS
Glaukos
3.7199 of 5 stars
$153.18
-2.1%
$147.75
-3.5%
+71.6%$8.45B$360.35M-50.72780Short Interest ↑
STVN
Stevanato Group
N/A€22.21
-3.2%
N/A-18.8%$6.56B$1.09B47.265,635Gap Down
BLCO
Bausch + Lomb
2.9754 of 5 stars
$17.36
-2.3%
$20.58
+18.6%
+19.0%$6.11B$4.68B-16.5313,300
INSP
Inspire Medical Systems
4.8651 of 5 stars
$180.23
-11.0%
$233.58
+29.6%
-11.4%$5.40B$755.59M168.441,011High Trading Volume
NARI
Inari Medical
1.6924 of 5 stars
$79.34
+0.1%
$68.00
-14.3%
+38.4%$4.64B$574.50M-58.77800
PRCT
PROCEPT BioRobotics
2.9036 of 5 stars
$81.01
-6.7%
$97.86
+20.8%
+66.9%$4.23B$199.84M-41.54430Positive News
Gap Down
NVST
Envista
3.4717 of 5 stars
$19.07
+2.6%
$20.21
+6.0%
-16.3%$3.28B$2.50B-2.4512,700
IRTC
iRhythm Technologies
1.3312 of 5 stars
$92.82
-5.0%
$108.45
+16.8%
-1.1%$2.91B$560.03M-19.101,790
NVCR
NovoCure
3.3166 of 5 stars
$26.79
-2.4%
$32.67
+21.9%
+87.2%$2.90B$577.74M-19.141,320Analyst Revision

Related Companies and Tools


This page (NASDAQ:LIVN) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners